Literature DB >> 10349690

Use of high-dose interferon in the treatment of chronic hepatitis C.

M L Shiffman1.   

Abstract

High-dose interferon therapy is defined as any treatment regimen that provides more than 3 million Units (MU) of interferon three times weekly (TIW), or more than 9 MU on a weekly basis. Such treatment could be achieved with either a fixed dose of interferon administered daily (QD) or TIW, an induction regimen in which doses greater than 3 MU QD are administered for several weeks to months followed by a reduction in the dose or dosing frequency, or by escalation in the interferon dose. Each of these high-dose regimens appears to increase end-of-treatment response. Unfortunately, sustained response and virologic "cure" following treatment with high-dose interferon appear no better than what could be achieved with standard-dose interferon therapy. Whether sustained response can be improved by utilizing ribavirin in combination with high-dose interferon remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349690

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  8 in total

Review 1.  Treatment of chronic hepatitis C in nonresponders to previous therapy.

Authors:  Todd E Dantzler; Eric J Lawitz
Journal:  Curr Gastroenterol Rep       Date:  2003-02

2.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

3.  The faster the better?

Authors:  Nicola Carulli
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

4.  Efficacy of daily induction dosing vs standard thrice weekly dosing of interferon-alpha2B for initial treatment of chronic hepatitis C.

Authors:  Hernando J Gonzalez; Samuel B Ho; John B Gross; Craig Peine; Daniel McKee; Theresa Smith
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

Review 5.  Chronic viral hepatitis C: management update.

Authors:  K S Gutfreund; V G Bain
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

Review 6.  Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?

Authors:  M L Shiffman
Journal:  Curr Gastroenterol Rep       Date:  2001-02

7.  Intensive interferon therapy does not increase virological response rates in African Americans with chronic hepatitis C.

Authors:  Dickens Theodore; Mitchell L Shiffman; Richard K Sterling; Christine J Bruno; Jeffrey Weinstein; Jeffrey S Crippin; Gabriel Garcia; Teresa L Wright; Hari Conjeevaram; Rajender K Reddy; Frederick S Nolte; Michael W Fried
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

8.  Hepatitis C.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.